Form4insider filings, from the source

SEC Form 4 · accession 0001470831-26-000688

C4 Therapeutics, Inc. · CCCC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 1, 2026
Accepted (ET)
Jul 2, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001662579

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jul 1, 2026A2,650$4.34A71,950D
Common StockF3holding———129,877IBy Kenneth C. Anderson 2021 Irrevocable Trust
Common StockF4holding———74,581IBy Kenneth C. Anderson 2015 Irrevocable Trust
Common StockF5holding———74,581IBy Cynthia E. Anderson 2015 Irrevocable Trust
Common StockF6holding———3,623IBy Kenneth C. Anderson Revocable Trust
Common StockF7holding———3,623IBy Cynthia E. Anderson Revocable Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses